STERIS Total Depreciation and Amortization - Cash Flow 2010-2024 | STE
STERIS annual/quarterly total depreciation and amortization - cash flow history and growth rate from 2010 to 2024. Total depreciation and amortization - cash flow can be defined as the total amount of depreciation and amortization listed on the Cash Flows Statement
- STERIS total depreciation and amortization - cash flow for the quarter ending December 31, 2024 was $0.354B, a 18.75% decline year-over-year.
- STERIS total depreciation and amortization - cash flow for the twelve months ending December 31, 2024 was $1.265B, a 33.95% decline year-over-year.
- STERIS annual total depreciation and amortization - cash flow for 2024 was $0.57B, a 45.75% decline from 2023.
- STERIS annual total depreciation and amortization - cash flow for 2023 was $1.051B, a 69.55% increase from 2022.
- STERIS annual total depreciation and amortization - cash flow for 2022 was $0.62B, a 182.69% increase from 2021.
| STERIS Annual Total Depreciation and Amortization - Cash Flow (Millions of US $) |
|
|---|---|
| 2024 | $570 |
| 2023 | $1,051 |
| 2022 | $620 |
| 2021 | $219 |
| 2020 | $197 |
| 2019 | $226 |
| 2018 | $178 |
| 2017 | $246 |
| 2016 | $144 |
| 2015 | $92 |
| 2014 | $76 |
| 2013 | $69 |
| 2012 | $63 |
| 2011 | $54 |
| 2010 | $56 |
| 2009 | $59 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $22.012B | $5.139B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $184.546B | 80.83 |
| Thermo Fisher Scientific (TMO) | United States | $161.389B | 19.52 |
| Alcon (ALC) | Switzerland | $47.559B | 31.61 |
| Edwards Lifesciences (EW) | United States | $44.842B | 29.34 |
| IDEXX Laboratories (IDXX) | United States | $35.412B | 40.95 |
| DexCom (DXCM) | United States | $27.957B | 43.21 |
| IQVIA Holdings (IQV) | United States | $27.056B | 14.97 |
| Mettler-Toledo (MTD) | United States | $22.200B | 25.88 |
| Waters (WAT) | United States | $20.277B | 28.71 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.073B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.659B | 14.96 |
| Hologic (HOLX) | United States | $13.095B | 14.13 |
| Sysmex ADR (SSMXY) | Japan | $11.834B | 0.00 |
| Penumbra (PEN) | United States | $11.498B | 90.25 |
| Globus Medical (GMED) | United States | $9.948B | 23.03 |
| Masimo (MASI) | United States | $8.815B | 36.99 |
| Teleflex (TFX) | United States | $6.409B | 9.87 |
| Glaukos (GKOS) | United States | $5.356B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.429B | 23.20 |
| TransMedics (TMDX) | United States | $3.126B | 91.51 |
| PROCEPT BioRobotics (PRCT) | United States | $3.115B | 0.00 |
| Veracyte (VCYT) | United States | $2.446B | 44.20 |
| Nihon Kohden (NHNKY) | Japan | $2.137B | 11.68 |
| LivaNova (LIVN) | United Kingdom | $2.047B | 12.43 |
| Elekta AB (EKTAY) | Sweden | $1.922B | 17.28 |
| Alphatec Holdings (ATEC) | United States | $1.638B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.340B | 6.78 |
| Pulse Biosciences (PLSE) | United States | $1.197B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.116B | 0.00 |
| Artivion (AORT) | United States | $1.024B | 95.96 |
| OPKO Health (OPK) | United States | $0.940B | 0.00 |
| AxoGen (AXGN) | United States | $0.732B | 0.00 |
| IRadimed (IRMD) | United States | $0.683B | 35.80 |
| Mesa Laboratories (MLAB) | United States | $0.638B | 13.94 |
| RxSight (RXST) | United States | $0.619B | 0.00 |
| SiBone (SIBN) | United States | $0.607B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.41 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.551B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.523B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.476B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.443B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.410B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.408B | 0.00 |
| NeuroPace (NPCE) | United States | $0.392B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.337B | 18.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.333B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.326B | 6.92 |
| Neuronetics (STIM) | United States | $0.292B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.198B | 0.00 |
| Inogen (INGN) | United States | $0.196B | 0.00 |
| 908 Devices (MASS) | United States | $0.196B | 0.00 |
| CVRx (CVRX) | United States | $0.193B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.163B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.163B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.133B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.121B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.103B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| InspireMD (NSPR) | Israel | $0.075B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.073B | 11.12 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.056B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.040B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |